PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Case report from Austria shows mpox breakthrough infection in man who had received both vaccine doses

A second case is currently under investigation

2024-03-30
(Press-News.org)

New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a ‘breakthrough’ mpox infection in January 2024. The authors believe breakthrough should be considered in fully vaccinated individuals engaging in high-risk behaviors. They also call for further research on the need for booster doses to protect against these breakthrough infections. The case report is by Dr Luigi Segagni-Lusignani, Public Health Authority, Vienna, Austria and colleagues. They add a second case, reported in the last few weeks (March 2024) is currently under investigation.

Following the sharp decline in notifications of new mpox infections after introducing the EMA-approved modified Vaccinia Ankara–Bavarian Nordic (MVA-BN) administration in late 2022 and early 2023, an upsurge in mpox cases occurred in the latter half of 2023 in European countries. Clusters were observed in individuals presumed immune through recent vaccination, but data on the durability of protective immunity after complete 2-dose vaccination are limited.

The authors here present a case of mpox infection in a 35-year-old, who had completed the two-dose course of intradermal third-generation Jynneos vaccine as pre-Exposure Prophylaxis (PrEP) on November 8, 2022, with a 28-day interval between the first and second dose. His medical history included well-controlled HIV infection since 2011 (CD4 count of > 700 cells/µL), hepatitis C infection in April 2017, SARS-CoV-2 infection in November 2020, and Campylobacter infections in August 2021 and January 2022.

In January 2024, five days after multiple sexual encounters during a Vienna event, the patient reported fever, chills, headache, discomfort urinating, diarrhoea with bleeding, and penile and anal itching. On day 3, a genital herpes infection was suspected, but no treatment was started. After two days, he presented to the dermatology clinic with worsening lymphadenopathy (swollen lymph nodes), where positive mpox virus PCR results were obtained. His Mpox Severity Score System (MPOX-SSS) was 10 (of a maximum score of 12).

No antiviral treatment was administered, no hospitalisation was required and the patient was home isolated. After 21 days, a control swab was still positive and the isolation had to be extended to day 25 from symptom onset, when finally all scabs fell off the lesions and PCR test on viral swab was negative.

The authors say: “This was Austria's first mpox breakthrough case. Despite no hospitalisation, the clinical course was not less severe than in unvaccinated patients, with longer disease duration and higher scores on the mpox severity scale. The 14-month interval between complete vaccination and infection suggests vaccine-induced immunity could be not durably protective. This case underscores the importance of clinical suspicion for mpox in high-risk groups, even if fully vaccinated with 2-doses. Breakthrough infections need to be explored further, as well as the possibility of vaccine boosters in vaccinated groups with epidemiological risky behaviours.”

They add: “The Austrian Vaccine Board updates its national mpox vaccine strategy annually based on new scientific evidence. Currently, there is no nationwide recommendation for booster shots after completing the currently recommend (Jynneos) vaccination regimen, even for high-risk groups. However, any potential changes to the vaccination strategy will depend on filling critical knowledge gaps in mpox immunity. These gaps include understanding the current level of immunity, the durability of immune responses, and the long-term vaccine effectiveness in high-risk groups.”

END



ELSE PRESS RELEASES FROM THIS DATE:

Scientists have a new tool in the race to improve the diagnosis and prognosis of sepsis

2024-03-29
Researchers from Lund University in Sweden have identified distinct molecular signatures associated with the clinical signs of sepsis that could provide more accurate diagnosis and prognosis of sepsis, as well as help to target specific therapies at patients who would benefit most, according to new research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April). “A simple blood test when combined with a personalised risk model has the potential to save lives by providing more accurate sepsis diagnosis and determining who may go on to develop more severe clinical ...

UK Biobank study identifies ideal body weight for adults with type 2 diabetes to minimise risk of dying from cardiovascular disease

2024-03-29
*This is an early press release from the European Congress on Obesity (ECO 2024) Venice 12-15 May. Please credit the Congress if using this material* New research being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May), identifies the optimum body weight range for adults with type 2 diabetes to minimise their risk of dying from any cardiovascular disease, including heart failure, heart disease, stroke, and chronic kidney disease. The findings, based on health data from the UK Biobank, indicate that for adults aged 65 years or younger, maintaining a body mass index (BMI) within the normal range of 23–25 kg/m² was associated with the ...

Social media images of pediatric craniofacial patients – parents voice concerns

2024-03-29
Waltham — March 29, 2024 — Parents voice strong concerns about social media sharing of images of children undergoing craniofacial surgery, reports a survey study in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.  "Pediatric plastic surgeons must understand that consent and assent are necessary before posting patient images online," comments senior author Kenneth L. Fan, MD, of Georgetown ...

Researchers produce grafts that replicate the human ear

Researchers produce grafts that replicate the human ear
2024-03-29
Researchers Produce Grafts that Replicate the Human Ear Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural. The study, published online in Acta Biomaterialia on March 16, offers the promise of grafts with well-defined anatomy and the correct biomechanical properties for those who are born with a congenital malformation or who lose an ear later in life. “Ear reconstruction requires multiple surgeries and an incredible amount of artistry ...

Hevolution Foundation issues $115 million call for applications for geroscience research opportunities

Hevolution Foundation issues $115 million call for applications for geroscience research opportunities
2024-03-29
BOSTON, United States  — 29 March, 2024  — Based on the success of its 2023 HF-GRO program effort, Hevolution Foundation is issuing a call for applications for the 2024 iteration of the program. HF-GRO is an international effort to accelerate progress in healthy aging research. The major goal is to identify and support research that will further the Hevolution’s mission of extending healthy lifespan for the benefit of all humanity.  HF-GRO will ...

Rice study identifies protein responsible for gas vesicle clustering in bacteria

Rice study identifies protein responsible for gas vesicle clustering in bacteria
2024-03-29
HOUSTON – (March 29, 2024) – Gas vesicles are hollow structures made of protein found in the cells of certain microorganisms, and researchers at Rice University believe they can be programmed for use in biomedical applications. “Inside cells, gas vesicles are packed in a beautiful honeycomb pattern. How this pattern is formed has never been thoroughly understood. We are presenting the first identification of a protein that can regulate this patterning, and we believe this will be a milestone in molecular microbiology,” said George Lu, assistant professor of bioengineering and a Cancer Prevention and Research Institute of Texas scholar. Lu and colleagues have published ...

AADOCR announces recipients of the 2024 Student Competition for Advancing Dental Research Application (SCADA)

2024-03-29
Alexandria, VA – The American Association for Dental, Oral, and Craniofacial Research (AADOCR) has named the recipients of the 2024 Student Competition for Advancing Dental Research Application (SCADA). The recipients were recognized during the Opening Ceremonies of the 53rd Annual Meeting of the AADOCR, which was held in conjunction with the 102nd General Session of the International Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024 in New Orleans, LA. The winners are: CLINICAL RESEARCH & PUBLIC HEALTH CATEGORY 1st ...

Veterans help provide greater insight into Klinefelter and Jacobs syndromes

2024-03-29
AURORA, Colo. (March 29,  2024) –Researchers at the University of Colorado Anschutz Medical Campus and collaborators across the country have conducted the largest and most diverse study of men with extra X or Y chromosomes in the US using a large dataset of military veterans. The results could lead to better diagnoses of these underrecognized conditions and earlier treatment of associated diseases. The study was published today in JAMA Network Open. “One in 400 males have an additional X or Y chromosome, however 86 percent of these individuals are not diagnosed,” said ...

Three renowned Argonne scientists accept joint appointments at the University of Houston

Three renowned Argonne scientists accept joint appointments at the University of Houston
2024-03-29
HOUSTON, March 29, 2024 – Three top researchers with the U.S. Department of Energy’s Argonne National Laboratory have accepted joint appointments in various capacities at the University of Houston. These appointments are part of the memorandum of understanding (MoU) Argonne signed recently with the Greater Houston Partnership. The MoU creates greater collaboration across academia, industry, private investors and government to accelerate and scale decarbonization efforts in the region, with the goal of achieving a net-zero emissions economy by 2050, according to an Argonne press release. “This strategic collaboration leverages the combined strengths ...

High-resolution images reveal similarities in protein structures between Alzheimer’s disease and Down syndrome

2024-03-29
INDIANAPOLIS – More than 90% of people with Down syndrome, the most common chromosomal disorder in humans and the most frequent genetic cause of intellectual disability, are diagnosed with Alzheimer’s disease by ages 55-60. A new study recently published in Nature Structural and Molecular Biology uses leading-edge cryo-electron microscopy imaging technology to determine whether differences exist between the protein structures in those with Alzheimer’s disease and those with both Alzheimer’s disease and Down syndrome. “Just like in Alzheimer’s disease, the neuropathological phenotype in those with ...

LAST 30 PRESS RELEASES:

Astronomers find the smallest main-belt asteroids ever detected

Mays Cancer Center hosts 47th San Antonio Breast Cancer Symposium, highlighting advances in treatment and care

CT radiomics and body composition for predicting hepatic decompensation

Loneliness and social isolation among US older adults

Loneliness and isolation: Back to pre-pandemic levels, but still high, for older adults

MIT astronomers find the smallest asteroids ever detected in the main belt

Health and lifestyle factors and dementia risk among former professional soccer players

Stress-related disorders among young individuals with surgical removal of tonsils or adenoids

RSV disease burden and nirsevimab effectiveness in young children from 2023-2024

Brain tumor organoids accurately model patient response to CAR T cell therapy

New method enables protein analysis accounting for population diversity

Breaking new ground in health care: Setting the standard for XR clinical research with the RATE-XR guideline

Unlocking worm strategies: A path to innovative vaccines and therapies

Students are less likely to feel safe at their schools, compared to staff and parents

SwRI announces joint industry program aimed at advancing heavy-duty hydrogen refueling infrastructure

Webb telescope’s largest study of universe expansion confirms challenge to cosmic theory

By age six, children think boys are better than girls at computing and engineering, new American Institutes for Research study shows

Hair growth drug safe at low doses for breast cancer patients

Giving a gift? Better late than never, study finds

Judging knots throws people for a loop

Not so simple machines: Cracking the code for materials that can learn

Finding the weak points: New method to prevent train delay cascades

New AI cracks complex engineering problems faster than supercomputers

Existing EV batteries may last up to 40% longer than expected

Breakthrough AI model can translate the language of plant life

MASH discovery redefines subtypes with distinct risks: shaping the future of fatty liver disease treatment

Three-quarters of Earth’s land became permanently drier in last three decades: UN

Lower-quality public housing is at high risk of flood damage

Study compares soft tissue sarcoma rates among U.S. military servicemen and men in the general population

Toxic air in Texas high schools

[Press-News.org] Case report from Austria shows mpox breakthrough infection in man who had received both vaccine doses
A second case is currently under investigation